Luisa M Salter-Cid

Title: Luisa M Salter-Cid: Innovator in Multiple Myeloma Treatment

Introduction

Luisa M Salter-Cid is a prominent inventor based in Princeton Junction, NJ (US). She has made significant contributions to the field of cancer treatment, particularly in the area of multiple myeloma. Her innovative work has led to the development of novel therapeutic methods that combine specific antibodies to enhance treatment efficacy.

Latest Patents

Luisa holds a patent for a groundbreaking invention titled "Combination of anti-KIR and anti-CS1 antibodies to treat multiple myeloma." This patent outlines methods for clinical treatment of multiple myeloma using an anti-KIR antibody in combination with an anti-CS1 antibody. This innovative approach aims to improve patient outcomes in the fight against this challenging disease.

Career Highlights

Throughout her career, Luisa has worked with notable companies in the pharmaceutical industry. She has been associated with Bristol-Myers Squibb Company and Innate Pharma, where she has contributed her expertise in antibody development and cancer research. Her work has been instrumental in advancing therapeutic options for patients suffering from multiple myeloma.

Collaborations

Luisa has collaborated with esteemed colleagues in her field, including Pascale Andre and Mathieu Blery. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately benefiting the research community and patients alike.

Conclusion

Luisa M Salter-Cid is a trailblazer in the development of innovative treatments for multiple myeloma. Her contributions to the field through her patent and collaborations with leading companies and researchers highlight her commitment to improving cancer therapies. Her work continues to inspire advancements in medical science and patient care.